BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10100423)

  • 1. [Is the lesion produced by oxidation a central part in the pathogenesis of Alzheimer's disease?].
    Perry G; Smith MA
    Neurologia; 1999 Feb; 14(2):78-84. PubMed ID: 10100423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease.
    Perry G; Castellani RJ; Hirai K; Smith MA
    J Alzheimers Dis; 1998 Mar; 1(1):45-55. PubMed ID: 12214011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.
    Varadarajan S; Yatin S; Aksenova M; Butterfield DA
    J Struct Biol; 2000 Jun; 130(2-3):184-208. PubMed ID: 10940225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics, lifestyle and the roles of amyloid beta and oxidative stress in Alzheimer's disease.
    Veurink G; Fuller SJ; Atwood CS; Martins RN
    Ann Hum Biol; 2003; 30(6):639-67. PubMed ID: 14675907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
    Reddy PH
    J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease.
    Polidori MC; Griffiths HR; Mariani E; Mecocci P
    Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free radical oxidative damage and Alzheimer's disease.
    Tuppo EE; Forman LJ
    J Am Osteopath Assoc; 2001 Dec; 101(12 Suppl Pt 1):S11-5. PubMed ID: 11794746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.
    Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P
    Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology.
    Bennett S; Grant MM; Aldred S
    J Alzheimers Dis; 2009; 17(2):245-57. PubMed ID: 19221412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of oxidant mechanisms in Alzheimer's disease.
    Moreira PI; Smith MA; Zhu X; Santos MS; Oliveira CR; Perry G
    Expert Rev Neurother; 2004 Nov; 4(6):995-1004. PubMed ID: 15853526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
    Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
    Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease.
    Atwood CS; Huang X; Moir RD; Tanzi RE; Bush AI
    Met Ions Biol Syst; 1999; 36():309-64. PubMed ID: 10093929
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxidative damage and Alzheimer's disease: are antioxidant therapies useful?
    Moreira PI; Smith MA; Zhu X; Honda K; Lee HG; Aliev G; Perry G
    Drug News Perspect; 2005; 18(1):13-9. PubMed ID: 15753972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Abdul HM; Calabrese V; Calvani M; Butterfield DA
    J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.
    Aliev G; Palacios HH; Walrafen B; Lipsitt AE; Obrenovich ME; Morales L
    Int J Biochem Cell Biol; 2009 Oct; 41(10):1989-2004. PubMed ID: 19703659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Free oxygen radiacals and kidney diseases--part I].
    Sakac V; Sakac M
    Med Pregl; 2000; 53(9-10):463-74. PubMed ID: 11320727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronically increased oxidative stress in fibroblasts from Alzheimer's disease patients causes early senescence and renders resistance to apoptosis by oxidative stress.
    Naderi J; Lopez C; Pandey S
    Mech Ageing Dev; 2006 Jan; 127(1):25-35. PubMed ID: 16188294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear and mitochondrial DNA oxidation in Alzheimer's disease.
    Santos RX; Correia SC; Zhu X; Lee HG; Petersen RB; Nunomura A; Smith MA; Perry G; Moreira PI
    Free Radic Res; 2012 Apr; 46(4):565-76. PubMed ID: 22149654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain.
    Korolainen MA; Goldsteins G; Nyman TA; Alafuzoff I; Koistinaho J; Pirttilä T
    Neurobiol Aging; 2006 Jan; 27(1):42-53. PubMed ID: 16298240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.